Vericel (VCEL) Cash & Equivalents (2010 - 2026)
Vericel (VCEL) reported Cash & Equivalents of $109.3 million for Q1 2026, up 48.73% on a YoY basis from $73.5 million in Q1 2025, and up 9.2% sequentially from $100.1 million in Q4 2025.
Vericel (VCEL) Cash & Equivalents (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 15 years of Cash & Equivalents data on file, last reported at $109.3 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Equivalents rose 48.73% year-over-year to $109.3 million; the trailing twelve-month figure through Mar 2026 stood at $109.3 million (up 48.73% YoY), and the FY2025 full-year result was $100.1 million, up 34.32% from the prior year.
- Cash & Equivalents climbed to $109.3 million in Q1 2026, from $100.1 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $109.3 million in Q1 2026 to a low of $43.0 million in Q2 2023.
- A 5-year average of $68.7 million and a median of $62.9 million in 2024 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents fell 25.26% in 2022 and surged 87.03% in 2025, its largest moves.
- Tracing VCEL's Cash & Equivalents over 5 years: stood at $51.1 million in 2022, then jumped by 35.29% to $69.1 million in 2023, then rose by 7.86% to $74.5 million in 2024, then soared by 34.32% to $100.1 million in 2025, then advanced by 9.2% to $109.3 million in 2026.
- Business Quant data shows VCEL's Cash & Equivalents at $109.3 million in Q1 2026, $100.1 million in Q4 2025, and $100.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 109.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109.30 Mn |
| Dec 31, 2025 | 100.09 Mn |
| Sep 30, 2025 | 100.40 Mn |
| Jun 30, 2025 | 80.50 Mn |
| Mar 31, 2025 | 73.49 Mn |
| Dec 31, 2024 | 74.52 Mn |
| Sep 30, 2024 | 53.68 Mn |
| Jun 30, 2024 | 50.29 Mn |
| Mar 31, 2024 | 62.94 Mn |
| Dec 31, 2023 | 69.09 Mn |
| Sep 30, 2023 | 60.47 Mn |
| Jun 30, 2023 | 43.02 Mn |
| Mar 31, 2023 | 61.83 Mn |
| Dec 31, 2022 | 51.07 Mn |
| Sep 30, 2022 | 65.22 Mn |
| Jun 30, 2022 | 56.05 Mn |
| Mar 31, 2022 | 55.66 Mn |
| Dec 31, 2021 | 68.33 Mn |
| Sep 30, 2021 | 54.55 Mn |
| Jun 30, 2021 | 51.76 Mn |